CliffBio

Rosemont Pharmaceuticals

Patent cliffs & loss of exclusivity

Liquid Medicines

Company

Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/rosemont-pharmaceuticals
LinkedIn URLhttps://www.linkedin.com/company/rosemont-pharmaceuticals-limited
Pitchbook URLhttps://pitchbook.com/profiles/company/11778-67
Seedtable URLhttps://seedtable.com/companies/rosemont-pharmaceuticals
Official Websitehttps://www.rosemontpharma.com

7 upcoming patent cliffs

DrugIngredientTypeCliff
  1. FIBRICORFENOFIBRIC ACIDSmall mol.Aug 2027
  2. FIBRICORFENOFIBRIC ACIDSmall mol.Aug 2027
  3. NEXICLON XRCLONIDINESmall mol.Sep 2031
  4. NEXICLON XRCLONIDINESmall mol.Sep 2031
  5. VOSTALLYRAMIPRILSmall mol.Aug 2039
  6. QDOLOTRAMADOL HYDROCHLORIDESmall mol.Sep 2040
  7. ATMEKSIMETHOCARBAMOLSmall mol.Oct 2044

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.